Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 17, 2025
November 17, 2025
40969c10-8c6c-42cb-b3eb-03f03eb9fa38
Related Documents
Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs: Guidance for Industry
Guidance DocumentJuly 31, 2026Center for Drug Evaluation and Research
Certain Postapproval Requirements and Resources for ANDAs
Guidance DocumentJune 4, 2026Center for Drug Evaluation and Research
Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of the Federal Food, Drug, and Cosmetic Act
Guidance DocumentDecember 22, 2025Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.